Page
%P
2 Result(s)
-
Article
Open AccessPrediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
It has been reported that pathological complete response is an important surrogate marker for disease-free survival and overall survival in patients with triple-negative breast cancer. This study investigates ...
-
Article
Open AccessKi67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
The pathological complete response (pCR) after neoadjuvant chemotherapy is a surrogate marker for a favorable prognosis in breast cancer patients. Factors capable of predicting a pCR, such as the proliferation...
